44932 Federal Register / Vol. 76, No. 144 / Wednesday, July 27, 2011 / Notices 

EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST

Cost Component Total cost Annualized 

cost 

Project Development ....................................................................................................................................................... $420,055 $84,011 

Data Collection Activities ................................................................................................................................................. 1,452,290 290,458 

Data Processing and Analysis, and Reports to AHRQ ................................................................................................... 141,637 28,327 

Project Management ........................................................................................................................................................ 291,706 58,341 

Overhead ......................................................................................................................................................................... 413,584 82,717 

Total .......................................................................................................................................................................... 2,719,272 543,854 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 

information collection are requested 

with regard to any of the following: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ healthcare 

research and healthcare information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: July 6, 2011. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2011–18790 Filed 7–26–11; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting of the National Advisory 

Council Subcommittee Identifying 

Quality Measures for Medicaid Eligible 

Adults 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ). 

ACTION: Notice of public meeting. 

SUMMARY: This notice announces a 

meeting of a Subcommittee of the 

National Advisory Council for 

Healthcare Research and Quality. 

DATES: The meeting will be held on 

Tuesday, August 9th from 10 a.m. to 6 

p.m., and Wednesday, August 10th from 

9 a.m. to 3 p.m. 

ADDRESSES: The meeting will be held at 

the Westin Washington, DC City Center, 

1400 M Street, NW., Washington DC. 

FOR FURTHER INFORMATION CONTACT: 

Nancy Wilson, MD MPH, Coordinator of 

the National Advisory Council 

Subcommittee Identifying Quality 

Measures for Medicaid Eligible Adults 

at the Agency for Healthcare Research 

and Quality, 540 Gaither Road, 

Rockville, Maryland, 20850, (301) 427– 

1310. For press-related information, 

please contact Karen Migdail at (301) 

427–1855. 

If sign language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact the 

Food and Drug Administration (FDA) 

Office of Equal Employment 

Opportunity and Diversity Management 

on (301) 827–4840, no later than August 

1, 2011. The agenda, roster, and meeting 

report will be available from Dr. Wilson. 

SUPPLEMENTARY INFORMATION: 

I. Purpose of the National Advisory 

Council Subcommittee Identifying 

Quality Measures for Medicaid Eligible 

Adults 

The purpose of the National Advisory 

Council Subcommittee Identifying 

Quality Measures for Medicaid Eligible 

Adults is to develop consensus on a 

core set of health quality measures for 

Medicaid-eligible adults. While a 

number of current efforts to assess, 

publicly report, and improve quality of 

care include Medicaid eligible adults, 

this core set of measures will reflect 

aspects of care particularly important to 

Medicaid recipients that are not 

currently assessed consistently and 

routinely. 

Section 2701 of the Affordable Care 

Act (ACA), which added Section 1139B 

to Title XI of the Social Security Act, 

requires the Secretary of Health and 

Human Services to identify and publish 

a recommended core set of health 

quality measures for Medicaid eligible 

adults. AHRQ and the Centers for 

Medicare and Medicaid Services (CMS) 

have entered into an interagency 

agreement to collaboratively identify 

these measures. Section 2701 also 

requires the Secretary, in consultation 

with States, to develop a standardized 

format for reporting information and to 

develop procedures that encourage 

voluntary reporting based on the initial 

core set of measures. The Secretary is 

also required to establish a Medicaid 

Quality Measurement Program that will 

fund the development, testing, and 

validation of emerging and innovative 

evidence-based measures and to 

subsequently publish recommended 

changes to the initial core measure set. 

Not later than September 30, 2014 and 

annually thereafter the Secretary is 

required to collect, analyze, and make 

publically available the information 

reported by the States. 

The National Advisory Council 

Subcommittee Identifying Quality 

Measures for Medicaid Eligible Adults 

met on October 18th and 19th 2010, and 

identified an initial core set of 

measures. These measures were 

subsequently posted in the Federal 

Register for a two month public 

comment period. This initial core set of 

measures must be finalized by January 

1, 2012. 

The purpose of the National Advisory 

Council Subcommittee Identifying 

Quality Measures for Medicaid Eligible 

Adults is to: (a) Review the public 

comment analysis, (b) determine and 

apply criteria by which the initial list is 

further refined, and (c) make 

recommendations to the National 

Advisory Council regarding finalizing 

the initial core set of measures. The 

National Advisory Council 

Subcommittee Identifying Quality 

Measures for Medicaid Eligible Adults 

membership will reflect expertise in 

healthcare quality measurement, 

healthcare disparities, and in the 

populations eligible for Medicaid. 

Elizabeth McGlynn, PhD, Director, 

Kaiser Permanente Center for 

Effectiveness & Safety Research, and 

Foster Gesten, M.D., Medical Director of 


sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 144 / Wednesday, July 27, 2011 / Notices 44933 

Office of Insurance Programs for New 

York, co-chair the SNAC. 

Role of the National Advisory Council 

The National Advisory Council for 

Healthcare Research and Quality is 

authorized by Section 941 of the Public 

Health Service Act, 42 U.S.C. 299c. In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director, Agency for 

Healthcare Research and Quality 

(AHRQ), on matters related to AHRQ’s 

conduct of its mission including 

providing guidance on (A) Priorities for 

health care research, (B) the field of 

health care research including training 

needs and information dissemination on 

health care quality and (C) the role of 

the Agency in light of private sector 

activity and opportunities for public 

private partnerships. 

The Council is composed of members 

of the public, appointed by the 

Secretary, and Federal ex-officio 

members specified in the authorizing 

legislation. 

II. Agenda 

The final agenda will be available on 

the AHRQ Web site at http:// 

www.AHRQ.gov no later than August 1, 

2011. 

Dated: July 8, 2011. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2011–18791 Filed 7–26–11; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket Number NIOSH–227] 

Determination on Adding Cancer, or a 

Certain Type of Cancer, to the List of 

WTC-Related Health Conditions 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC) 

announces the availability of the ‘‘First 

Periodic Review of Scientific and 

Medical Evidence Related to Cancer for 

the World Trade Center Health 

Program.’’ The Review can be found at: 

http://www.cdc.gov/niosh/topics/wtc/ 

prc/prc-1.html. 

Background: The James Zadroga 9/11 

Health and Compensation Act of 2010 

(Pub. L. 111–347), Title XXXIII of the 

Public Health Service Act, 124 Stat. 

3623 (codified at 42 U.S.C. 300mm– 

300mm–61) requires in Section 300mm– 

22(a)(5)(A) that the Administrator of the 

World Trade Center (WTC) Health 

Program ‘‘periodically conduct a review 

of all available scientific and medical 

evidence, including findings and 

recommendations of Clinical Centers of 

Excellence, published in peer-reviewed 

journals to determine if, based on such 

evidence, cancer or a certain type of 

cancer should be added to the 

applicable list of WTC-related health 

conditions.’’ 

The first periodic Review of Cancer 

provides a summary of the current 

scientific and medical findings in the 

peer-reviewed literature about 

exposures resulting from the September 

11, 2001 terrorist attacks in New York 

City and cancer studies. The review 

discusses criteria that have been used 

previously to assist in weighing the 

scientific evidence to determine if a 

causal association exists between 

exposure and cancer. The review 

summarizes input from the public on 

three questions regarding conditions 

relating to cancer for consideration 

under the WTC Health Program, as 

requested in the Federal Register on 

March 8, 2011 (76 FR 12740) and 

modified on March 29, 2011 (76 FR 

17421). See http://www.cdc.gov/niosh/ 

docket/archive/docket227.html. 

The review also provides reports from 

the Mount Sinai School of Medicine, the 

Bureau of Health Services of the Fire 

Department of New York City, the WTC 

Health Registry of the New York City 

Department of Health and Mental 

Hygiene and the New York State 

Department of Health about cancer 

studies ongoing or planned. 

Based on the scientific and medical 

findings in the peer-reviewed literature 

reported in the first periodic Review of 

Cancer for the WTC Health Program, 

insufficient evidence exists at this time 

to propose a rule to add cancer, or a 

certain type of cancer, to the List of 

WTC-Related Health Conditions found 

at 42 U.S.C. 300mm–22(a)(3) through (4) 

and 300mm–32(b). 

FOR FURTHER INFORMATION CONTACT: 

Jessica Bilics, NIOSH, Patriots Plaza 1, 

395 E Street, SW., Suite 9200, 

Washington, DC 20201, E-mail 

WTC@cdc.gov. 

Dated: July 19, 2011. 

John Howard, 

Administrator, World Trade Center Health 

Program; and Director, National Institute for 

Occupational Safety and Health, Centers for 

Disease Control and Prevention. 

[FR Doc. 2011–18754 Filed 7–26–11; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

Statement of Organization, Functions, 

and Delegations of Authority 

Part F of the Statement of 

Organization, Functions, and 

Delegations of Authority for the 

Department of Health and Human 

Services, Centers for Medicare & 

Medicaid Services (CMS), (Federal 

Register, Vol. 75, No. 56, pp. 14176– 

14178, dated March 24, 2010; as 

amended at Vol. 76, No. 17, p. 4703, 

dated January 26, 2011; as amended at 

Vol. 76, No. 75, pp. 21908–21909, dated 

April 19, 2011) is amended to reflect the 

establishment of the Office of Minority 

Health. 

Part F is described below: 

• Section FC. 10 (Organization) reads 

as follows: 

Office of the Administrator (FC) 

Office of Equal Opportunity and Civil 

Rights (FCA) 

Office of Legislation (FCC) 

Office of the Actuary (FCE) 

Office of Strategic Operations and 

Regulatory Affairs (FCF) 

Office of Clinical Standards and Quality 

(FCG) 

Center for Medicare (FCH) 

Center for Medicaid, CHIP and Survey 

& Certification (FCJ) 

Center for Strategic Planning (FCK) 

Center for Program Integrity (FCL) 

Chief Operating Officer (FCM) 

Office of Minority Health (FCN) 

Center for Medicare and Medicaid 

Innovation (FCP) 

Federal Coordinated Health Care Office 

(FCQ) 

Center for Consumer Information and 

Insurance Oversight (FCR) 

Office of Public Engagement (FCS) 

Office of Communications (FCT) 

• Section FC. 20 (Functions) reads as 

follows: 

Office of Minority Health (FCN) 

• Serves as the principal advisor and 

coordinator to the Agency for the 

special needs of minority and 

disadvantaged populations. 

• Provides leadership, vision and 

direction to address HHS and CMS 


sroberts on DSK5SPTVN1PROD with NOTICES